Evidence map›Paper›PMID 41708676›Full record

ArticleScientific reports2026

Optimizing a dynamic infrared emitter by tailoring titanium carbide MXene surface chemistry.

Neda Daliran, Ali Reza Oveisi, Zhiming Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Neda DaliranInstitute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 611731, PR China.
Ali Reza OveisiDepartment of Organic Chemistry, Faculty of Chemistry, Lorestan University, Khorramabad, 68151-44316, Iran. oveisi.a@lu.ac.ir.
Zhiming WangInstitute of Fundamental and Frontier Sciences, University of Electronic Science and Technology of China, Chengdu, 611731, PR China. zhmwang@uestc.edu.cn.

Funding

Iran National Science Foundation Project Number: 4028293University of Electronic Science and Technology of China "111 Project" (No. B20030)
6 · The paper itself

Abstract

Ti3C2Tx MXene has become a highly promising material in nanophotonics because of its exceptional optical and thermal properties, which can be tailored through surface terminations. For the first time, we examine how Ti3C2Tx MXene without (N) and with different surface terminations (-F, -O-, or -OH) affects the performance of a thermal emitter with negative differential emissivity. This emitter is composed of Tungsten doped VO2 (W-doped VO2) composite/SiO2/Ti3C2Tx MXene. W doping in VO2 enables reversible-hysteresis emissivity behavior at a low critical temperature (~ 315 K), accompanied by negative differential emissivity between high- and low-temperature phases. While the threshold temperature for emissivity remains consistent across all terminations, the average differential emissivity varies considerably. Comparative analysis shows notable differences in differential average emissivity across surface terminations: -0.51 (W-doped VO2/SiO2/Ti3C2(OH)2), -0.49 (W-doped VO2/SiO2/Ti3C2F2), -0.46 (W-doped VO2/SiO2/Ti3C2), and − 0.32 (W-doped VO2/SiO2/Ti3C2O2), with hydroxyl termination demonstrating superior performance. This work highlights how engineering MXene surface terminations can enable tunable negative emissivity modulation at low temperatures, offering promising applications in thermal control devices, light modulation, infrared tagging and identification, solar energy harvesting systems, and other fields.

Indexed as

EmissivityMXeneSurface terminationThermal emitterW-doped VO2 composite

Identifiers

PMID41708676
PMCPMC13013665

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.